2026 Annual Meeting | N3 - Neuroscience in the Clinic: The Connection Between GLP and GIP Medications and Brain Health: A New Frontier

Date Monday 04/20/26

Time 01:00 PM - 03:00 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) James J. Sejvar, MD, FAAN, Aparna Wagle-Shukla, MD, FAAN

Topic(s) General Neurology

CME Available 2.00 CME credits

Program Tracks Brain Health

Event Timeline
No timeline events available at this time.

Faculty Disclosures
James J. Sejvar, MD, FAAN	Dr. Sejvar has nothing to disclose.
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.

��ɫ����